Parmax Pharma Limited (PARMAX.BO) Stock Overview
Explore Parmax Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.
Parmax Pharma Limited (PARMAX.BO)
Key Financials
Key Financials
Market Cap
458.3M
P/E Ratio
-11.02
EPS (TTM)
$-11.12
ROE
0.96%
PARMAX.BO Stock Analysis & Investment Overview (BSE)
Our AI-powered analysis of Parmax Pharma Limited (BSE: PARMAX.BO) gives investors deep insight into how the stock performs on the BSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Parmax Pharma Limited's BSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PARMAX.BO on the BSE shows an RSI of 83.21, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $45.75 for the BSE listing.
Key metrics behind Parmax Pharma Limited's BSE-traded stock include a P/E ratio of -11.02 and a market capitalization of 458.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PARMAX.BO on the BSE.